The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2008Validation of the NR2D Subunit of the NMDA Receptor as a Therapeutic Target for Parkinson's Disease
Objective/Rationale:
The NMDA receptor is a protein that helps to mediate communication between neurons. The brain makes several different kinds of NMDA receptors, sometimes termed NR2A, NR2B, NR2C... -
Target Validation, 2008NR2B as a Therapeutic Target in Parkinson's Disease
Objective/Rationale:
The loss of striatal dopamine that accompanies Parkinson’s disease disrupts the function of the neurotransmitter glutamate within this same region. Glutamate transmission involves...
-
Target Validation, 2008SIRT1 Activators as Therapy for Parkinson's Disease
Objective/Rationale:
Resveratrol is a compound that activates a protetin, SIRT1, which is known to protect against stresses associated with neurodegeneration, including oxidative damage and protein... -
Therapeutics Development Initiative, 2008Novel Gastric Retentive Controlled-release Dosage Forms of Levodopa/Carbidopa: in vivo Assessment in Pre-Clinical Models
Objective/Rationale:
The objective of this project is to develop gastric retentive controlled-release tablets of levodopa/carbidopa that will result in more constant blood levels of levodopa compared... -
Therapeutics Development Initiative, 2008Passive Immunotherapy for Parkinson's Disease based on Naturally Occurring Autoantibodies against alpha-Synuclein
Objective/Rationale:
We suggest a novel approach for the treatment of Parkinson's disease based on anti-alpha-synuclein monoclonal antibodies. This treatment concept offers a preventive approach in... -
Therapeutics Development Initiative, 2008Cerebrospinal Fluid Biomarkers of Microtubule-mediated Axonal Transport for Monitoring of Disease Progression and Therapeutic Interventions in Parkinson's Disease
Objective/Rationale:
Techniques for measuring in humans the activity of brain chemical pathways that are fundamentally involved in the initiation, progression or reversal of Parkinson’s disease would...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.